Labcorp Launches Convenient Self-Collection Options for Women
Labcorp, a global leader in laboratory services, is excited to announce the rollout of self-collection options for HPV and sexually transmitted infections (STIs), enhancing screening alternatives nationwide. This initiative allows women to access essential health tests with increased privacy and comfort, addressing common barriers to cervical cancer and STI screenings.
The self-collection solution for HPV testing is now FDA-approved, enabling women to assess their risk of cervical cancer effectively. Alongside this, Labcorp offers a vaginal swab option specifically for STI testing, available at Labcorp's extensive network of Patient Service Centers (PSCs) across the United States.
Dr. Brian Caveney, Labcorp's chief medical and scientific officer, emphasized the importance of this offering: "Many patients hesitate or avoid screenings due to discomfort or concerns about stigma. With these self-collection options, we aim to reduce barriers that prevent individuals from taking charge of their health routine. Our services allow patients to undergo testing at their convenience, fostering a more proactive approach to their health and well-being."
Significance of HPV and STI Self-Collection
Every year, cervical cancer affects thousands of women, making screening vital. Unfortunately, statistics reveal that a significant portion of women are not up to date with their cervical cancer screenings. By enabling self-collection, Labcorp aims to increase awareness and encourage more women to participate in essential screening.
Dr. Caveney further stated, "Cervical cancer is preventable, yet screening rates remain alarmingly low in the U.S. By providing an easy and less invasive screening method, we can help improve participation and ultimately reduce the incidence of this disease. Our self-collection offerings significantly improve access and convenience, reaching those who might skip traditional exams due to barriers."
Convenient and Discreet Testing for STIs
In addition to HPV testing, Labcorp is introducing self-collection kits for various STIs, including chlamydia, gonorrhea, trichomonas, and mycoplasma genitalium (Mgen). The CDC reports soaring STI rates, with millions of cases diagnosed annually, highlighting the urgent need for solutions that facilitate testing and treatment.
Dr. Caveney remarked, "The discomfort associated with STI tests can deter individuals from seeking necessary screenings, which is critical for ensuring proper health management. Our self-collection option empowers individuals, allowing them to take control of their sexual health privately and reduce the timeframe between diagnosis and treatment, leading to better health outcomes."
Key Features of Labcorp's Offerings
Labcorp's self-collection tests will have several key features designed to enhance the user experience:
- Tests for both HPV and STIs can be ordered by a physician and conducted in the comfort of a healthcare setting or at any Labcorp PSC.
- Results are promptly sent to both the physician and the patient through their Labcorp Patient account.
- If a test result is positive, patients are encouraged to follow up with their healthcare provider to discuss treatment options.
Beginning on a specified launch date, patients will have access to these self-collection solutions, providing a robust pathway to better health management.
About Labcorp
Labcorp (NYSE: LH) is a premier provider of innovative laboratory services that support healthcare professionals, pharmaceutical companies, and patients across the globe. With nearly 70,000 employees, Labcorp operates in approximately 100 countries and plays a critical role in advancing science and improving health care. Each year, the company conducts over 700 million tests to help make clear and confident medical decisions, ensuring better health outcomes for individuals worldwide.
Frequently Asked Questions
What self-collection tests is Labcorp offering?
Labcorp is offering self-collection tests for HPV and various sexually transmitted infections, including chlamydia and gonorrhea.
How does self-collection improve access to testing?
Self-collection allows patients to conduct tests in a private and comfortable setting, which can encourage more individuals to undergo necessary screenings.
When will these self-collection options be available?
Labcorp's self-collection options are set to launch on a specified date, allowing patients to test conveniently at their own pace.
How quickly will I receive my test results?
Labcorp ensures that test results are sent electronically to both the healthcare provider and the patient through their Labcorp Patient account promptly after testing.
What should I do if I receive a positive result?
If a test returns positive, patients are advised to follow up with their physician for further discussion about treatment options.
